Security key
872381108
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 44,406,200
- Total 13F shares
- 6,476,845
- Share change
- -289,064
- Total reported value
- $50,649,000
- Price per share
- $7.82
- Number of holders
- 26
- Value change
- -$2,643,965
- Number of buys
- 14
- Number of sells
- 10
Report period
Q1 2020
Institutions
26
Top holders
10
TELA full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
TELA Bio, Inc. SEC filings
TELA Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 872381108
Recent filing periods:
Top shareholders of TELA - TELA Bio, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.8%
|
3,027,542
|
$39,207,000 | — | 31 Dec 2019 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.6%
|
1,139,358
|
$14,755,000 | — | 31 Dec 2019 | |
| Essex Woodlands Management, Inc. |
13F
|
Company |
1.7%
|
769,231
|
$9,962,000 | — | 31 Dec 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.9%
|
400,000
|
$5,180,000 | — | 31 Dec 2019 | |
| Woodline Partners LP |
13F
|
Company |
0.51%
|
228,534
|
$2,960,000 | — | 31 Dec 2019 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.45%
|
201,471
|
$2,609,000 | — | 31 Dec 2019 | |
| Opaleye Management Inc. |
13F
|
Company |
0.39%
|
175,000
|
$2,266,000 | — | 31 Dec 2019 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.25%
|
109,600
|
$1,419,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.12%
|
54,423
|
$705,000 | — | 31 Dec 2019 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.12%
|
53,239
|
$689,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.11%
|
50,000
|
$647,000 | — | 31 Dec 2019 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.06%
|
27,471
|
$355,000 | — | 31 Dec 2019 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.06%
|
25,000
|
$324,000 | — | 31 Dec 2019 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.05%
|
23,831
|
$309,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
23,429
|
$303,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
16,181
|
$210,000 | — | 31 Dec 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
11,886
|
$154,000 | — | 31 Dec 2019 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.02%
|
10,900
|
$141,000 | — | 31 Dec 2019 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
10,900
|
$141,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
10,348
|
$134,000 | — | 31 Dec 2019 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.02%
|
10,000
|
$130,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
5,889
|
$77,000 | — | 31 Dec 2019 |
Institutional Holders of TELA Bio, Inc. - Common Stock (TELA) as of Q1 2020
As of 31 Mar 2020,
TELA Bio, Inc. - Common Stock (TELA) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,476,845 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, Essex Woodlands Management, Inc., COWEN AND COMPANY, LLC, Alyeska Investment Group, L.P., FEDERATED HERMES, INC., Opaleye Management Inc., Pentwater Capital Management LP, VANGUARD GROUP INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
22
Q1 2020 holders
26
Holder diff
4
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.